Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Cancers”

432 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 432 results

Testing effectiveness (Phase 2)WithdrawnNCT03778879
What this trial is testing

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Who this might be right for
Adenocarcinoma of the PancreasPancreas Cancer
Alan Katz
Not applicableStudy completedNCT03273374
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Gangnam Severance Hospital 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297
What this trial is testing

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more
Shanghai Zhongshan Hospital 50
Not applicableLooking for participantsNCT05298722
What this trial is testing

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Who this might be right for
Pancreatic Cancer
University Hospital, Ghent 45
Testing effectiveness (Phase 2)Ended earlyNCT01897454
What this trial is testing

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage IIA Pancreatic CancerStage IIB Pancreatic Cancer+1 more
Albert Einstein College of Medicine 23
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)Ended earlyNCT02288377
What this trial is testing

A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)

Who this might be right for
Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
Federation Francophone de Cancerologie Digestive 53
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Looking for participantsNCT06690528
What this trial is testing

Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Who this might be right for
Pancreatic Cancer Metastatic
Azienda Ospedaliera di Padova 56
Testing effectiveness (Phase 2)Looking for participantsNCT05132504
What this trial is testing

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Baylor College of Medicine 30
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Not applicableStudy completedNCT02777463
What this trial is testing

The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 28
Testing effectiveness (Phase 2)Study completedNCT04385992
What this trial is testing

Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET

Who this might be right for
Neuroendocrine Tumors
IRCCS San Raffaele 31
Very early researchStudy completedNCT03153410
What this trial is testing

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05908747
What this trial is testing

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 29
Large-scale testing (Phase 3)Looking for participantsNCT04969731
What this trial is testing

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
GC Cell Corporation 408
Not applicableLooking for participantsNCT05524090
What this trial is testing

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectable+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 223
Not applicableStudy completedNCT06630910
What this trial is testing

New Technique of Pancreaticojejunostomy During Whipple Operation

Who this might be right for
Periampullary Carcinoma ResectablePancreatic TumorsDuodenal Neoplasms
Theodor Bilharz Research Institute 48
Testing effectiveness (Phase 2)UnknownNCT02717091
What this trial is testing

Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Cancer
Nagoya University 50
Testing effectiveness (Phase 2)Study completedNCT03146962
What this trial is testing

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Who this might be right for
Colorectal CancerPancreatic CancerLung Cancer
Weill Medical College of Cornell University 61
Load More Results